S-ICDs: advantages and opportunities for improvement

Area of Science:

• Cardiology
• Medical Device Technology

Background:

• The subcutaneous implantable cardioverter defibrillator (S-ICD) is a third-generation device.
• It has been integrated into clinical practice and guidelines.
• Significant advancements have occurred since its introduction over a decade ago.

Purpose of the Study:

• To review the current literature on the S-ICD.
• To discuss the safety, efficacy, and limitations of the S-ICD.

Main Methods:

• A literature search was conducted using PubMed.
• Articles related to the S-ICD were identified and reviewed.

Main Results:

• The S-ICD therapy is demonstrated as safe and effective.
• It is a valuable treatment option for specific patient populations.

Conclusions:

• The S-ICD is a proven therapy with existing shortcomings.
• Future iterations of the S-ICD are expected to overcome current limitations.